Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013607 |
---|---|
Receipt number | R000015893 |
Scientific Title | Observational study of Pertuzumab,Trastuzumab and taxane combination therapy for patient with pretreated HER2-positive advanced or recurrent breast cancer. |
Date of disclosure of the study information | 2014/04/02 |
Last modified on | 2017/04/05 08:44:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/04/02 11:44:45 | ||
2 | Update | 2017/04/05 08:43:57 | Name of primary person or sponsor Organization |
|
3 | Update | 2017/04/05 08:44:47 | Recruitment status |